The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines.
about
Neurokinin-1 receptor antagonists as antitumor drugs in gastrointestinal cancer: A new approachBiological and Pharmacological Aspects of the NK1-ReceptorG protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenuesA conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareTargeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic ApproachP2X7 receptors trigger ATP exocytosis and modify secretory vesicle dynamics in neuroblastoma cells.SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47DThe substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.Synthesis and preliminary evaluation of a new (99m)tc labeled substance p analogue as a potential tumor imaging agent.Involvement of substance P and the NK-1 receptor in pancreatic cancer.Neurokinin-1 receptor is a novel positive regulator of Wnt/ β-catenin signaling in melanogenesis.NK-1 as a melanoma target.NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011.Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis.Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues.Neuroendocrine factors: The missing link in non‑melanoma skin cancer (Review).Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells.Association of genetic variants in tachykinins pathway genes with colorectal cancer risk.The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines.The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines.Immunolocalization of full-length NK1 tachykinin receptors in human tumors.The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell Lines.Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood-brain barrier during extravasation and brain invasion.Neuroendocrine Factors and Head and Neck Squamous Cell Carcinoma: An Affair to Remember.The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer
P2860
Q26739681-541C30CA-6913-4940-8153-D7DE8D8E8020Q26784074-8EF5B4D4-84F8-4581-95B0-4FAF0D85EBD6Q26825769-7FF46423-29CC-4592-947B-DD1ED7BD04EFQ26851160-52E0EF05-EA31-4503-A410-25786BDCF246Q28085005-42F8F58D-EDD6-45C3-B29F-45C1382EB64AQ30499106-7A596259-A758-4E4B-AD00-BC0292CC91D9Q33933654-120C0E24-BF34-419B-A486-01BCF7770031Q34475975-BB664204-2F1C-46D9-959B-FF56F92C8FBCQ34777749-4406C886-F196-4020-B0CE-2A1582D936D5Q37617971-C2DD46FC-9C68-4883-9AC1-623A80819B3EQ37697149-627328C7-F8F2-4097-BA73-78C16B987E99Q37876914-B843E5D0-4030-49DE-8CBA-DE8C4A818632Q38018635-E046C654-D527-49F0-8CE6-34525414DCEDQ38112273-C10F634E-8524-4FBC-8609-E38CF72D7E8CQ38391996-0EDDC212-46FE-411F-8FD2-38F452E83106Q38676352-6CC0D612-3E0F-4A01-9BFB-335745E25E09Q38816965-7FB47306-5A98-49DA-897C-401D80730601Q39596926-BBBD246F-852C-4BFA-84B5-B84982A363C8Q39625473-79822847-07B1-42E5-9EF0-01CCD47BD856Q39705448-D2BC8094-C414-4BE6-AFDB-C0CA9D90B97AQ40285095-A46E1239-94F3-4DD3-9CC8-3BFE8AD529EFQ42875830-40D095F7-5DF8-4D15-AA10-C2CA6CB2393BQ43628974-47A5AB61-39D4-4F61-BC74-9B2BE34927EDQ55020898-4BD9A4A3-3282-4566-A423-F4BE3803622EQ58914868-FB4C1E56-C5B1-4494-9677-9BDF475D21DE
P2860
The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The NK1 receptor is involved i ...... lastoma and glioma cell lines.
@en
type
label
The NK1 receptor is involved i ...... lastoma and glioma cell lines.
@en
prefLabel
The NK1 receptor is involved i ...... lastoma and glioma cell lines.
@en
P2093
P1433
P1476
The NK1 receptor is involved i ...... lastoma and glioma cell lines.
@en
P2093
C Zamarriego
J I Piruat
P304
P356
10.1016/J.NPEP.2005.03.004
P577
2005-08-01T00:00:00Z